Jump to main content
Jump to site search


Smart diagnostic nano-agents for cerebral ischemia

Author affiliations

Abstract

Cerebral ischemia (or ischemic stroke) is undeniably one of the most important life-threatening cerebral disorders. It occurs due to a clot formation in one of the blood arteries supplying the brain, causing a reduction or interruption of the blood flow. To date, the use of thrombolytics like the recombinant tissue plasminogen activator or the use of mechanical thrombectomy are the only two food and drug administration-approved treatments. However, these cannot be applied without first evaluating the beneficial or adverse effects on the patient. Thus, imaging is decisive for identifying the appropriateness of each stroke patient, leading potentially to improved therapeutic outcomes. In this review, we will present a variety of diagnostic nano-agents, and a few theranostic ones, for the assessment of ischemic stroke, highlighting their strengths and weaknesses.

Graphical abstract: Smart diagnostic nano-agents for cerebral ischemia

Back to tab navigation

Article information


Submitted
29 Jan 2020
Accepted
26 Feb 2020
First published
26 Feb 2020

J. Mater. Chem. B, 2020, Advance Article
Article type
Review Article

Smart diagnostic nano-agents for cerebral ischemia

C. Tapeinos, M. Battaglini, A. Marino and G. Ciofani, J. Mater. Chem. B, 2020, Advance Article , DOI: 10.1039/D0TB00260G

Social activity

Search articles by author

Spotlight

Advertisements